<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Laboratory testing for disorders of neutrophil number or function</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Laboratory testing for disorders of neutrophil number or function</h1>
<div class="graphic"><div class="figure"><div class="ttl">Laboratory testing for disorders of neutrophil number or function</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Diagnosis</td> <td class="subtitle1">Initial testing</td> <td class="subtitle1">Genetic testing*</td> <td class="subtitle1">Additional details</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Disorders of neutrophil number</td> </tr> <tr> <td class="indent1">Severe congenital neutropenia (SCN)</td> <td>CBC, BM evaluation</td> <td>ELANE (mutation in approximately 60%), TCIRG1, G6PC3, GFI1, WAS, CSF3R, HAX1<sup>¶</sup>; 20 to 30% do not have a mutation identified</td> <td> <p>CBC shows isolated neutropenia</p> BM shows promyelocytic (progranulocyte) arrest</td> </tr> <tr> <td class="indent1">Cyclic neutropenia (CN)</td> <td>Serial CBCs (eg, two times per week)</td> <td>ELANE mutation in approximately 90%</td> <td>CBC shows isolated neutropenia with a characteristic periodicity (eg, absolute neutrophil count &lt;200/microL for two to four days). BM not helpful.</td> </tr> <tr> <td class="indent1">MonoMAC</td> <td>CBC, lymphocyte subsets</td> <td>GATA2 mutation in approximately 80%</td> <td>Varying neutropenia, severe monocytopenia, NK cell cytopenia, B cell lymphopenia</td> </tr> <tr> <td class="indent1">Shwachman-Diamond syndrome (SDS)</td> <td>CBC, tests of exocrine pancreatic function, BM evaluation</td> <td>SBDS mutation in approximately 80%</td> <td> <p>CBC shows isolated neutropenia or pancytopenia</p> BM shows decreased cellularity; laboratory tests show exocrine pancreatic dysfunction</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Disorders of neutrophil function</td> </tr> <tr> <td class="indent1">Chediak-Higashi syndrome (CHS)</td> <td>CBC, BM evaluation</td> <td>LYST mutation in approximately 80%</td> <td>Characteristic very large granules in leukocytes</td> </tr> <tr> <td class="indent1">Leukocyte adhesion deficiency-I (LAD-I)</td> <td>CBC, flow cytometry for deficiency of CD11b/CD18</td> <td>ITGB2 mutation in over 90%</td> <td>Neutrophilic leukocytosis, omphalitis in newborn period</td> </tr> <tr> <td class="indent1">Leukocyte adhesion deficiency-II (LAD-II)</td> <td>CBC, flow cytometry for deficiency of CD15a/SLeX</td> <td>GDP-fucose transporter</td> <td>Dysmorphic, neuro development problems</td> </tr> <tr> <td class="indent1">Chronic granulomatous disease (CGD)</td> <td>Flow cytometry using dihydrorhodamine (DHR) fluorescence; NBT slide test</td> <td>CYBB, NCF1, CYBA, or NCF2 mutation in most cases</td> <td> </td> </tr> <tr> <td class="indent1">Neutrophil specific granule deficiency</td> <td>CBC</td> <td>C/EBP-epsilon</td> <td>Bilobed neutrophils (pseudo Pelger-Huet anomaly) that lack granules</td> </tr> <tr> <td class="indent1">Hyperimmunoglobulin E (IgE) syndrome (Job syndrome)</td> <td>CBC, IgE levels, Th-17 cell count</td> <td>STAT3</td> <td> </td> </tr> </tbody></table></div><div class="graphic_lgnd">Refer to UpToDate topics on laboratory testing of neutrophil function and on specific disorders for further details.</div><div class="graphic_footnotes">CBC: complete blood count with exam of smear; BM: bone marrow; ANC: absolute neutrophil count; NBT: nitro blue tetrazolium.<br/>* The genetic disorders associated with neutropenia or neutrophil dysfunction syndromes can be diagnosed with reasonable certainty by combinations of the tests listed above, which are available through certified clinical reference laboratories. Refer to UpToDate topics on neutropenia and neutrophil dysfunction for details and caveats regarding testing and additional clinical features of these syndromes.<br/>¶ HAX1 mutation is rare and essentially only seen in consanguineous pairings.</div><div id="graphicVersion">Graphic 100391 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
